Cardiovascular News Issue 51—September 2018 US edition

In our latest issue, we report on the top stories from the 2018 ESC Congress—including MITRAL.FR, CULPRIT-SHOCK (one-year data), and Low Risk TAVR. We...

Cardiovascular News Issue 51—September 2018

In our latest issue, we report on the top stories from the 2018 ESC Congress—including MITRAL.FR, CULPRIT-SHOCK (one-year data), and Low Risk TAVR. We...

Cardiovascular News Issue 50—August 2018 US edition

In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRAl HTN-ON, ORBITA FFR/iFR analysis, and FAME (five-year results). We also...

Cardiovascular News Issue 50—August 2018

In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRAl HTN-ON, ORBITA FFR/iFR analysis, and FAME (five-year results). We also...

Cardiovascular News Issue 49—May 2018 US edition

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of Cardiology Scientific Session – including...

Cardiovascular News Issue 49—May 2018

For our May 2018 edition (Issue 49), we report on the key studies from the 2018 American College of Cardiology Scientific Session - including...

Cardiovascular News Issue 48—March 2018 US edition

In this edition of Cardiovascular News (issue 48, US edition), we report on the top stories from TCT 2017—including: ORBITA, CULPRIT-SHOCK and the cost-effectiveness data from...

Cardiovascular News Issue 48—March 2018

In this edition of Cardiovascular News (issue 48), we report on the top stories from TCT 2017—including: ORBITA, CULPRIT-SHOCK and the cost-effectiveness data from...

Cardiovascular News Issue 47 – November 2017 US edition

Highlights: SPYRAL HTN-OFF MED provides "proof of principle" that renal denervation lowers blood pressure Rate of target lesion failure significantly lower with Orsiro than...

Cardiovascular News Issue 47 – November 2017

Highlights: SPYRAL HTN-OFF MED provides "proof of principle" that renal denervation lowers blood pressure Rate of target lesion failure significantly lower with Orsiro than...

Cardiovascular News Issue 46 – September 2017 US edition

To mark angioplasty’s ruby anniversary, in this issue (47; September 2017), we bring you a case report on the first-ever PCI & and review how technology...

Cardiovascular News Issue 46 – September 2017

To mark angioplasty's ruby anniversary, in this issue (47; September 2017), we bring you a case report on the first-ever PCI & and review how technology...

Cardiovascular News Issue 45 – May 2017 US edition

The top story this issue (45; May 2017) reviews whether iFR, following the results of DEFINE-FLAIR and SWEDEHEART, is set to become the new...

Cardiovascular News Issue 45 – May 2017

The top story this issue (45; May 2017) reviews whether iFR, following the results of DEFINE-FLAIR and SWEDEHEART, is set to become the new...

Cardiovascular News Issue 44 – February 2017 US edition

In Issue 44 (February 2017), we review why EXCEL and NOBLE had such different findings for left main PCI, the three-year outcomes of the ABSORB...

Cardiovascular News Issue 44 – February 2017

In Issue 44 (February 2017), we review why EXCEL and NOBLE had such different findings for left main PCI, the three-year outcomes of the ABSORB...

Cardiovascular News Issue 43 – November 2016 US Edition

Highlights: Lower revascularisation rate means drug-eluting stents are still preferred despite no long-term survival benefit; Optical coherence tomography significantly improves functional outcomes after PCI;...

Cardiovascular News Issue 43 – November 2016

Highlights: Lower revascularisation rate means drug-eluting stents are still preferred despite no long-term survival benefit; Optical coherence tomography significantly improves functional outcomes after PCI;...

Cardiovascular News Issue 42 – August 2016 US Edition

Highlights: Study indicates signal for valve degeneration in TAVI patients by eight years; Absorb now available in the USA following FDA approval; Profile of Philip...

Cardiovascular News Issue 42 – August 2016

Highlights: Study indicates signal for valve degeneration in TAVI patients by eight years; Absorb now available in the USA following FDA approval; Profile of Philip...

Cardiovascular News Issue 41 – May 2016

Highlights - TAVI with Sapien 3 may be better than surgery for intermediate-risk patients; Deferred stenting in STEMI patients does not improve outcomes; Usman...

Cardiovascular News Issue 41 – May 2016 US Edition

Highlights - TAVI with Sapien 3 may be better than surgery for intermediate-risk patients; Deferred stenting in STEMI patients does not improve outcomes; Usman...

Cardiovascular News Issue 40 – February 2016 US Edition

Highlights - ABSORB III supports previous findings that Absorb is noninferior to Xience at one year; IVUS-guided stent implantation significantly reduces risk of major...

Cardiovascular News Issue 40 – February 2016

Highlights - ABSORB III supports previous findings that Absorb is noninferior to Xience at one year; IVUS-guided stent implantation significantly reduces risk of major...

Cardiovascular News Issue 39 – October 2015

Highlights - Novel diagnostic strategy may "dramatically reduce need for invasive tests"; New tools needed for optimising dual antiplatelet therapy duration; Marco Roffi on...

Cardiovascular News Issue 39 – October 2015 US edition

Highlights - Novel diagnostic strategy may "dramatically reduce need for invasive tests"; New tools needed for optimising dual antiplatelet therapy duration; Marco Roffi on...

Cardiovascular News Issue 38 – August 2015

Highlights: -Sapien XT and CoreValve have comparable mortality at one year -Current recommendations on multivessel PCI may need to be reconsidered -Maciej Lesiak: PCI...

Cardiovascular News Issue 38 – August 2015 US Edition

Highlights: -Sapien XT and CoreValve have comparable mortality at one year -Current recommendations on multivessel PCI may need to be reconsidered -Maciej Lesiak: PCI...

Cardiovascular News Issue 37 – May 2015 US Edition

Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest CoreValve should be preferred option for high-risk patients" -Wayne Batchelor:...

Cardiovascular News Issue 37 – May 2015

Highlights: -In BEST, surgery is still top option for multivessel disease -Two-year data "suggest CoreValve should be preferred option for high-risk patients" -Wayne Batchelor:...

Cardiovascular News Issue 36 – February 2015

Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial of Absorb indicates device has similar one-year clinical...

Cardiovascular News Issue 36 – February 2015 US Edition

Highlights: -More data needed for routine use of TAVI in lower risk patients -First randomised trial of Absorb indicates device has similar one-year clinical...

Cardiovascular News Issue 35 – September 2014

Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients...

Cardiovascular News Issue 35 – September 2014 US Edition

Highlights: -European guidelines lower duration of dual antiplatelet therapy to six months or less -Fractional flow reserve is safe and feasible in NSTEMI patients...

Cardiovascular News Issue 34 – August 2014

Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert...

Cardiovascular News Issue 34 – August 2014 US Edition

Highlights: -Staged intervention is right way to treat STEMI patients with multivessel disease -No incidences of severe paravalvular leak with next-generation TAVI devices -Robert...

Cardiovascular News Issue 33 – May 2014

Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than...

Cardiovascular News Issue 33 – May 2014 US Edition

Highlights: - Renal denervation comes to a "grinding halt" but studies will continue - One-year survival is significantly better with self-expanding TAVI device than...

Cardiovascular News Issue 32 – February 2014

Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by...

Cardiovascular News Issue 32 – February 2014 US Edition

Highlights: -Major setback for renal denervation -Long-term dual antiplatelet therapy may not always be needed -The use of vascular robotic systems for PCI, by...

Cardiovascular News Issue 31 – October 2013

Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be...

Cardiovascular News Issue 31 – October 2013 US Edition

Highlights: -Preventative angioplasty in non-infarct arteries benefits STEMI patients -PCI and bypass graft surgery: Which intervention and in whom? -Unilateral renal denervation may be...

Cardiovascular News issue 30 – August 2013

Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in...

Cardiovascular News issue 30 – August 2013 US edition

Highlights: -Six to 12 months is the right timeframe for dual antiplatelet therapy-Questions raised about bivalirudin's superiority over heparin-How to negotiate tortuous arteries in...

Cardiovascular News issue 29 – May 2013

Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce...

Cardiovascular News issue 29 – May 2013 US edition

Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce...

Cardiovascular News Issue 27 – October 2012 US edition

Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with...

Cardiovascular News Issue 27 – October 2012

Highlights: -TRILOGY-ACS shows no advantage for prasugrel over clopidogrel -Renal denervation may be cost-effective for resistant hypertension -German registry shows TAVI restricted to high-risk patients and with...

Cardiovascular News Issue 26 – August 2012 US edition

Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy...

Cardiovascular News Issue 26 – August 2012

Highlights: -The future of renal denervation rests on selecting the right patient -FAME II trial preliminary results show FFR-guided angioplasty superior to medical therapy...

Cardiovascular News Issue 25 – May 2012

Highlights: -TAVI as effective as surgery in high-risk patients at two years -Sustained blood pressure reduction achieved with renal denervation out to three years...

Cardiovascular News Issue 24 – February 2012 EU edition

Highlights: -iFR vasodilator-free measure of stenosis severity comparable to FFR -PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery -MRI safe in patients with selected...

Cardiovascular News Issue 24 – February 2012 US edition

Highlights: -iFR vasodilator-free measure of stenosis severity comparable to FFR -PARTNER A: Transfemoral TAVI improves quality of life, costs vs. surgery -MRI safe in patients with selected...

Cardiovascular News Issue 23 – November 2011

Highlights: -Lower thrombosis risk with newer generation drug-eluting stents -Intra-aortic balloon counterpulsation does not appear to provide benefit -"Prasugrel or ticagrelor should be administered to patients at...

Cardiovascular News Issue 22 – August 2011

Highlights: -FFR-CT technique can cut unnecessary coronary procedures -"TAVI should be performed with cerebral protection" -Pioneer of interventional cardiology in China receives Ethica Award 2011 -Profile: Martyn Thomas http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-22.pdf  

Cardiovascular News Issue 21 – May 2011

Highlights: -PARTNER find TAVI as good as surgery -Absorb shows positive one-year safety and efficacy results -Profile: Ralph Brindis http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-21.pdf  

Cardiovascular News Issue 20 – Feb 2011

Highlights - New absorbable stent era begins - TAVI improves quality of life in inoperable patients - Profile: Roberto Ferrari http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-20.pdf  

Cardiovascular News Issue 19 – Sept 2010

Highlights - ESC sees SHIFT in heart failure treatment - FDA advisory committe recommends approval of tricagrelor for acute coronary syndromes - Interview - George Dangas - New...

Cardiovascular News Issue 18 – Jul 2010

Highlights - "Encouraging" TAVI results in high-risk patients - Bioresorbable stent one step closer to becoming reality - Profile: Josep Brugada http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/18-Cardiovascular-Int_low-res.pdf  

Cardiovascular News Issue 17 – Apr 2010

Highlights - NO ACCORDance on role of fibrates - Cypher versus ENDEAVOR trial results cause stir - Profile: Christopher Paul Cannon http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/17-Cardiovascular-News_for-Web.pdf  

Cardiovascular News Issue 16 – Jan 2010

Highlights - Controversy surrounds long-term lipid lowering therapy - SPIRIT IV and COMPARE trials show positive results - Profile: Alfredo Galassi http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/16-Cardiovascular-News_for-Web.pdf  

Cardiovascular News Issue 15 – Sep 2009

Highlights - New drugs steal the spotlight at the ESC Congress - SYNTAX at two years: Comparable outcomes for stenting and bypass surgery in complex patients -...

Cardiovascular News Issue 14 – Aug 2009

Highlights - Drug-eluting stents "warranted" for infarction - Syntax Score website: A tool for the best strategy - Profile: Silvia Priori http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-14.pdf  

Cardiovascular News Issue 13 – May 2009

Highlights - Percutaneous mitral valve repair takes off - Antiplatelet agent prasugrel receives CE mark - Profile: Christian Hamm http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-13.pdf  

Cardiovascular News Issue 12 – Jan 2009

Highlights - JUPITER: reduced events in patients with low LDL cholesterol, raised CRP - FFR-guided stenting improves outcomes with fewer devices in the FAME trial http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/14/2016/06/Cardiovascular-News-12.pdf

Olaf Wendler

Juan F Granada

Ron Waksman

(Visited 1,383 times, 7 visits today)